Local leaders hope the recruitment campaign will help attract candidates amid a nationwide shortage of doctors.

The holding company as a whole posted an organic revenue decrease of 1.8% for Q4 and a 0.2% organic increase for all of last ...

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS Secretary.

For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

Royalty Pharma is giving Biogen $250 million for its lupus treatment litifilimab, which is currently in Phase 3 development ...

Senate advances RFK Jr.’s HHS bid; NIH deputy abruptly resigns; FDA approves SpringWorks’ genetic disorder drug.

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...

Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

This renewed interest in DB presented Tarsus with an opportunity to reup its efforts to combat a pressing yet often overlooked health condition.

Total headcount fell 1,000, as job reductions more than offset the acquisition of 2,000-strong Flywheel, and the agency group ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...